Rosuvastatin calcium NDC 71205-008

NDC codes

FDA NDC Directory

Product NDC (as listed)71205-008Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71205-0008Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71205-008-30	71205000830	30 TABLET, FILM COATED in 1 BOTTLE (71205-008-30)Marketed from Apr 2, 2018
71205-008-60	71205000860	60 TABLET, FILM COATED in 1 BOTTLE (71205-008-60)Marketed from Apr 2, 2018
71205-008-90	71205000890	90 TABLET, FILM COATED in 1 BOTTLE (71205-008-90)Marketed from Apr 2, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Rosuvastatin calcium
Generic name (nonproprietary): rosuvastatin calcium
Active ingredients: Rosuvastatin calcium — 10 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Proficient Rx LP
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 206434
Marketing start: Oct 31, 2016
Listing expires: Dec 31, 2026
Other FDA classes: Hydroxymethylglutaryl-CoA Reductase Inhibitors (Mechanism)
Identifiers: Product ID 71205-008_d0887230-770f-41c5-8887-83ec83afc378SPL ID d0887230-770f-41c5-8887-83ec83afc378SPL set ID 5a874865-3cbe-4589-9787-046feb9a2c46RxCUI 859747UNII 83MVU38M7QUPC 0371205008307
Pharmacologic class: HMG-CoA Reductase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471205000830 followed by a unit qualifier and the quantity

Package 71205-0008-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 1, 2022.

Indications (excerpt from the label)

Pediatric use information for patients 7 to 17 years of age is approved for AstraZeneca’s CRESTOR (rosuvastatin calcium) tablets. However, due to AstraZeneca’s marketing exclusivity rights, this drug product is not labeled with that pediatric information. Rosuvastatin calcium tablets are an HMG Co‑A reductase inhibitor indicated for: • adult patients with hypertriglyceridemia as an adjunct to diet (1.3) • adult patients with primary dysbetalipoproteinemia (Type III hyperlipoproteinemia) as an adjunct to diet (1.4) • adult patients with homozygous familial hypercholesterolemia (HoFH) to reduce LDL‑C, total-C, and ApoB (1.5) Limitations of use (1.8) : • Rosuvastatin calcium tablets have not be…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)